FDA official issues warning about looming biosimilar void
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyProduct developmentRegulatory Intelligence/PolicyRegulatory strategySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)